Solid Biosciences (SLDB) EBITDA (2017 - 2026)
Solid Biosciences (SLDB) reported EBITDA of -$56.99 million for Q2 2026, compared with -$41.31 million a year earlier.
Powered by 
Analysis
Solid Biosciences (SLDB) EBITDA (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Solid Biosciences' EBITDA came in at -$210.52 million; for FY2025, it came in at -$177.57 million.
- By year, EBITDA came in at -$127.27 million in FY2024, -$101.67 million in FY2023, -$104.04 million in FY2022 and -$69.29 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly EBITDA in data going back to Q1 2017.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$56.91 million (Q1 2026), -$48.94 million (Q4 2025) and -$47.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Solid Biosciences | 1.05 Bn | 1.05 Bn | - | -56.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -56.99 Mn |
| Mar 31, 2026 | -56.91 Mn |
| Dec 31, 2025 | -48.94 Mn |
| Sep 30, 2025 | -47.68 Mn |
| Jun 30, 2025 | -41.31 Mn |
| Mar 31, 2025 | -39.65 Mn |
| Dec 31, 2024 | -39.41 Mn |
| Sep 30, 2024 | -34.78 Mn |
| Jun 30, 2024 | -26.55 Mn |
| Mar 31, 2024 | -26.54 Mn |
| Dec 31, 2023 | -21.68 Mn |
| Sep 30, 2023 | -22.53 Mn |
| Jun 30, 2023 | -26.14 Mn |
| Mar 31, 2023 | -31.33 Mn |
| Dec 31, 2022 | -34.03 Mn |
| Sep 30, 2022 | -20.69 Mn |
| Jun 30, 2022 | -24.66 Mn |
| Mar 31, 2022 | -24.66 Mn |
| Dec 31, 2021 | -17.89 Mn |
| Sep 30, 2021 | -17.28 Mn |
API Access
Solid Biosciences EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=SLDB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "SLDB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=SLDB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();